Hospital admissions prior to primary intracerebral haemorrhage and relevant factors associated with survival



      Identification and modification of risk factors are essential for preventing intracerebral hemorrhage (ICH). Prior hospital admissions provide opportunities to intervene. We reported hospital admissions prior to primary ICH and investigated factors associated with survival.


      Cohort design using patient-level data from the Australian Stroke Clinical Registry (2009-2013) linked with hospital administrative datasets from four states (VIC, NSW, WA, QLD). Prior hospital admission is divided into within 90 days and more than 90 days prior to the index ICH event. The International Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification codes were used to define principal diagnoses of previous admissions/presentations and comorbidities. Factors associated with survival after ICH were investigated using Cox proportional hazards regression.


      Among 15,482 admissions for stroke, 2,098 (14%) had an ICH (median age 76 years, 52% male), 1,732 patients (83%) had a prior hospital admission, including 440 patients (21%) within 90 days of their index ICH admission. Patients with prior admission were older, had more comorbidities, and greater hospital frailty risk score than those without prior admission. Diseases of the circulatory system (14%) were the most common principal diagnoses for hospital admissions prior to ICH. Of the comorbidities associated with survival, neoplasms conferred the greatest hazard of death at 180 days after ICH (adjusted hazard ratio 1.42, 95% confidence interval 1.15 – 1.76, p = 0.001).


      Hospital presentations in the 90 days prior to ICH are common. Future research should be focussed on identifying opportunities for preventing ICH.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Poon MT
        • Fonville AF
        • Al-Shahi Salman R
        Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2014; 85: 660-667
        • Hemphill JC
        • Greenberg Steven M
        • Anderson Craig S
        • et al.
        Guidelines for the management of spontaneous intracerebral hemorrhage.
        Stroke. 2015; 46: 2032-2060
        • Cadilhac DA
        • Lannin NA
        • Anderson CS
        • et al.
        Protocol and pilot data for establishing the Australian stroke clinical registry.
        Int J Stroke. 2010; 5: 217-226
        • Kilkenny MF
        • Kim J
        • Andrew NE
        • et al.
        Maximising data value and avoiding data waste: a validation study in stroke research.
        Med J Aust. 2019; 210: 27-31
        • Charlson ME
        • Pompei P
        • Ales KL
        • et al.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chron Dis. 1987; 40: 373-383
        • Schmidt M
        • Jacobsen JB
        • Johnsen SP
        • et al.
        Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity.
        Neurology. 2014; 82: 340-350
        • Gilbert T
        • Neuburger J
        • Kraindler J
        • et al.
        Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study.
        Lancet. 2018; 391: 1775-1782
        • Cadilhac DA
        • Kilkenny MF
        • Levi CR
        • et al.
        Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR).
        Med J Aust. 2017; 206: 345-350
        • O'Donnell MJ
        • Chin SL
        • Rangarajan S
        • et al.
        Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
        The Lancet. 2016; 388: 761-775
        • Lee SH
        • Kim BJ
        • Ryu WS
        • et al.
        White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study.
        Neurology. 2010; 74: 1502-1510
        • Hevesi M
        • Bershad EM
        • Jafari M
        • et al.
        Untreated hypertension as predictor of in-hospital mortality in intracerebral hemorrhage: A multi-center study.
        J Crit Care. 2018; 43: 235-239
        • Sacco S
        • Marini C
        • Toni D
        • et al.
        Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry.
        Stroke. 2009; 40: 394-399
        • Steiner T
        • Weitz Jeffrey I
        • Veltkamp R
        Anticoagulant-associated intracranial hemorrhage in the era of reversal agents.
        Stroke. 2017; 48: 1432-1437
        • Fang J
        • Cui L
        • Liu M
        • et al.
        A retrospective study of the characteristics and clinical significance of a-waves in amyotrophic lateral sclerosis.
        Front Neurol. 2017; 8: 515
        • Morgan A
        • Joshy G
        • Schaffer A
        • et al.
        Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants.
        PloS one. 2018; 13e0208824
        • Foerch C
        • Lo EH
        • van Leyen K
        • et al.
        Intracerebral hemorrhage formation under direct oral anticoagulants.
        Stroke. 2019; 50: 1034-1042
        • Steiner T
        • Weitz JI
        • Veltkamp R
        Anticoagulant-associated intracranial hemorrhage in the era of reversal agents.
        Stroke. 2017; 48: 1432-1437
        • Wong GK
        • Lam SW
        • Wong A
        • et al.
        MoCA-assessed cognitive function and excellent outcome after aneurysmal subarachnoid hemorrhage at 1 year.
        Eur J Neurol. 2014; 21: 725-730
        • Falanga A
        • Russo L
        • Milesi V
        The coagulopathy of cancer.
        Curr Opin Hematol. 2014; 21: 423-429
        • Abid KA
        • Vail A
        • Patel HC
        • et al.
        Which factors influence decisions to transfer and treat patients with acute intracerebral haemorrhage and which are associated with prognosis? A retrospective cohort study.
        BMJ Open. 2013; 3e003684